RBLX is trading 11.68% up at $53.12 today after Arete Research upgraded the stock to Buy, attaching a $95 price target.
- The upgrade provides a clear company-specific catalyst for the strong rebound, contradicting the original news's claim of a "lack of fresh company-specific catalysts".
- This follows a period of significant weakness for the stock, which had shed more than half its value over the past year.
- The rally also coincides with a broader recovery in tech stocks, with investors rotating back into high-growth names.